• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

J&J to Spend More on R&D With Tax Reform Money

biospaceJanuary 25, 2018

Tag: Johnson & Johnson , Tax


Johnson & Johnson is promising to spend more on research in the health-care sector after changes to the U.S. tax system.

But for now, the world’s biggest health-care company isn’t providing many details on how it may use the extra money from lower tax rates.

"We’re going to look at all of our opportunities but it’s going to be a significant increase," Chief Financial Officer Dominic Caruso said Tuesday in an interview on Bloomberg TV.

Previous:Chinese Tycoon Eyes $500M IPO of Luye Life Sciences' Clinic Arm

Next:Why This Heart Drug Could Be a $5B Blockbuster for Novartis

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

J&J to Spend More on R&D With Tax Reform Money | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

98% up by HPLC Paclitaxel Side Chain (Azelidinone) 1-Benzoyl-3-(1-Ethoxyethoxy)-4-Phenyl-2-Azetidino

98% up by HPLC Paclitaxel Side Chain (Azelidinone) 1-Benzoyl-3-(1-Ethoxyethoxy)-4-Phenyl-2-Azetidino
Herba Taxilli Extract

Herba Taxilli Extract
Cefotaxime Sodium

Cefotaxime Sodium
PACLITAXEL (ALBUMIN BOUND)FOR INJECTION

PACLITAXEL (ALBUMIN BOUND)FOR INJECTION
Docetaxel

Docetaxel
paclitaxel injection prefilled

paclitaxel injection prefilled
Natural Astaxanthin

Natural Astaxanthin
Paclitaxel side chain, Methyl (2R,3S)-N-Boc-3-Phenylisoserine

Paclitaxel side chain, Methyl (2R,3S)-N-Boc-3-Phenylisoserine
Docetaxel

Docetaxel
Taxifolin

Taxifolin

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service